Company · CIK 0001826892 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BioAtla, Inc. · BCAB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 FForm 4 → | Sep 2, 5:28 pm EDT | Eric SieversChief Medical Officer | 134 | $1.69 | $226 | 11,346 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:27 pm EDT | Jay M Short Ph.D.Chief Executive Officer, Director | 259 | $1.69 | $438 | 52,035 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:26 pm EDT | Christian VasquezChief Financial Officer | 71 | $1.69 | $120 | 10,476 | — | |
| Mar 12, 2026 FForm 4 → | Jun 5, 4:30 pm EDT | Jay M Short Ph.D.Chief Executive Officer, Director | 898 | $1.25 | $1,125 | 52,294 | — | late |
| Mar 11, 2026 FForm 4 → | Jun 5, 4:30 pm EDT | Christian VasquezChief Financial Officer | 257 | $1.37 | $352 | 10,347 | — | late |
| Mar 11, 2026 FForm 4 → | Jun 5, 4:30 pm EDT | Eric SieversChief Medical Officer | 494 | $1.19 | $587 | 11,840 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.